Under construction – not a live service
Sign in
Taking people in BrazilNo phase

Registry collects samples and data from young people with rare brain tumors

Collects tissue samples and health records from young people with rare brain tumors.

Plain-language title generated from the registry record
Registry title: International Rare Brain Tumor Registry

Key facts

Where
São Paulo, BrazilSee the site

Where in Brazil

  • TUCCA - Santa MarcelinaSão Paulo, BrazilTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Children's National Research Institute
Trial code
NCT05697874
Record updated
7 August 2026
Original description
The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.Read full original descriptionShow less

International Rare Brain Tumor Registry

The objective of the International Rare Brain Tumor Registry (IRBTR) is to better understand rare brain tumors through the collection of biospecimens and matched clinical data of children, adolescents, and young adult patients diagnosed with rare brain tumors.

Inclusion: Patients with a known or suspected CNS Sarcoma; Patients with a known or suspected BCOR-altered brain tumor; Patients with a known or suspected Astroblastoma/NM-1 altered brain tumor; Patients with known or suspected histologically ambiguous/unclassifiable brain tumor; Patients with a known or suspected rare brain tumor; Signed informed consent by patient/ parent or guardian (assent where applicable) to participate in the study.

Exclusion: The patient is older than 46 years of age at diagnosis; The patient has an extra-CNS primary tumor; The patient or family is not willing to participate or does not sign informed consent.

ClinicalTrials.gov NCT05697874